|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
Carc. 2; Acute Tox. 4; Eye Irrit. 2
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
Aniline
EC / List no:
200-539-3
| CAS no:
62-53-3
|
-
|
-
|
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
Benzidine
EC / List no:
202-199-1
| CAS no:
92-87-5
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
Repr. 2; Acute Tox. 2; Acute Tox. 3; Skin Sens. 1
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
Carc. 1B; Acute Tox. 3; Skin Sens. 1
|
|
|
Details
|
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1
|
|
|
Details
|
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
|
|
|
Details
|
|
-
|
-
|
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
|
|
|
Details
|
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)
|
|
Details
|
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
EC / List no:
-
| CAS no:
70136-72-0
Sulfonium, [4-[(2-methyl-1-oxo-2-propenyl)oxy]phenyl]diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1), polymer with 2-ethyltricyclo[3.3.1.13,7]dec-2-yl 2-methyl-2-propenoate, 3-hydroxytricyclo[3.3.1.13,7]dec-1-yl 2-methyl-2-propenoate and tetrahydro-2-oxo-3-furanyl 2-methyl-2-propenoate
EC / List no:
-
| CAS no:
911027-69-5
|
-
|
-
|
|
VPVB very Persistent and very Bioaccumulative (article 57e)
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
Unst. Expl.; Acute Tox. 3
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
Details
|
Selenourea
EC / List no:
211-129-9
| CAS no:
630-10-4
Residues, zinc refining flue dust wastewater, mercury-selenium
The hot gases obtained by the roasting of raw zinc concentrate are cooled and cleaned from dust by passing through a spray of dilute sulfuric acid and/or water. This acid and/or water is filtered; the solid residue contains most of the volatile components of the concentrates to be roasted.
EC / List no:
309-609-9
| CAS no:
100403-63-2
Selenium
EC / List no:
231-957-4
| CAS no:
7782-49-2
|
-
|
-
|
|
|
|
Details
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
Details
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
Details
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
Details
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
Details
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
Details
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
Details
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
Details
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
Details
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
Details
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
Details
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
Details
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
Details
|
|
|
|
|
|
|
|